QuickView for TRIP12;jsessionid=704E499B4FE4E691F2F70BFE2E967E00;jsessionid=0F8FD2F7BA203C18D167A816EB0033CF;jsessionid=79B6A7C2CAACF664E3E557480D843667;jsessionid=E5822BEEC941B027FECDE0682F372DED;jsessionid=C91E2A71305C487F588DF0DCABE6815B (gene)

1. Mild iron overload induces TRIP12-mediated degradation of YY1 to trigger hepatic inflammation.
2. The neurodevelopmental and facial phenotype in individuals with a TRIP12 variant.
3. TRIP12 ubiquitination of glucocerebrosidase contributes to neurodegeneration in Parkinson's disease.
4. The oncogenic E3 ligase TRIP12 suppresses epithelial-mesenchymal transition (EMT) and mesenchymal tr…
5. E3 Ubiquitin Ligase TRIP12: Regulation, Structure, and Physiopathological Functions.

There were no clinical trials for TRIP12;jsessionid=704E499B4FE4E691F2F70BFE2E967E00;jsessionid=0F8FD2F7BA203C18D167A816EB0033CF;jsessionid=79B6A7C2CAACF664E3E557480D843667;jsessionid=E5822BEEC941B027FECDE0682F372DED;jsessionid=C91E2A71305C487F588DF0DCABE6815B